Designed for differential diagnosis of breast cancer and target search for drug treatment.
The test system has 3 lines of 5 markers:
|List of markers|
|Estrogen receptor (ER)|
|Progesterone receptors (РGR)|
|Her2-neu (EGFR 2)|
The development helps optimise the tumour antigenic status analysis process in case of breast cancer while reducing the time and cost of the study and preserving the same information contents.